Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/11/20 → 7/23/24 |
Funding
- INC Research, LLC ((OE) Prot #1951-CL-0101 // (OE) Prot #1951-CL-0101)
- Astellas Pharma Global Development, Inc. ((OE) Prot #1951-CL-0101 // (OE) Prot #1951-CL-0101)
Prot #1951-CL-0101: A Phase 1b Study of ASP1951, a GITR Agonistic Antibody, as a Single Agent and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
- Mulcahy, Mary Frances (PD/PI)
Project: Research project